Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT04496050
Eligibility Criteria:
Inclusion Criteria:
* Newborn babies who are hospitalized in Hacettepe University Faculty of Medicine İhsan Doğramacı Children's Hospital Neonatal Intensive Care Unit and who are receiving prostaglandin E1 infusion due to PDA-dependent congenital heart disease.
* Newborns who have the above criteria and whose consent form has been enlightened by their parents has been read and accepted to participate in the study.
Exclusion Criteria:
* Babies whose consent to participate in the study cannot be obtained.
* Babies with chromosomal disease or hereditary metabolic disease
* Babies who died during the first week of life and whose ultrasonography measurements could not be obtained.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
28 Days
Study:
NCT04496050
Study Brief:
Protocol Section:
NCT04496050